GLP-1 Trends GLP-1s are a class of medications originally approved for type 2 diabetes management that have seen dramatic growth in prescribing following expanded approvals for chronic weight management
In Phase II trials: Efinopegdutide (Merck/Johnson & Johnson/Hanmi Harma), VK2735 (Viking Therapeutics), BGM0504 (BrightGene), Pemvidutide (Altimmune/Spitfire Pharma), AMG133 (Amgen), Dapiglutide (Zealand Pharma), etc
12-in-1 Support Formula for Metabolism & Wellness: NutraPep GLP-1 Support Capsules are formulated with 12 carefully chosen ingredients, including Berberine, Cinnamon, Resveratrol, Raspberry Ketones, and Probiotics
Participants reported that 79 % of the food items were consumed at home with 93 %, 96 %, 97 %, and 84 % eating breakfast, lunch, dinner, and snacks, respectively
Please always inform your doctor before taking, and avoid self-determined combinations
Microdose GLP-1 products can be administered either as weekly injections or daily oral tablets